CASI Pharmaceuticals
CASI
#11079
Rank
C$5.99 M
Marketcap
C$0.29
Share price
0.00%
Change (1 day)
-87.37%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -C$66.38 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are C$26.84 Million. In 2024 the company made an earning of -C$53.51 Million a decrease over its 2023 earnings that were of -C$37.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$66.38 Million24.06%
2024 -C$53.51 Million44.35%
2023 -C$37.07 Million-29.55%
2022 -C$52.61 Million4.43%
2021 -C$50.38 Million-24.56%
2020 -C$66.78 Million4.74%
2019 -C$63.76 Million65.13%
2018 -C$38.62 Million155.07%
2017 -C$15.14 Million13.93%
2016 -C$13.29 Million31.18%
2015 -C$10.13 Million-72.5%
2014 -C$36.83 Million356.62%
2013 -C$8.07 Million-60.55%
2012 -C$20.45 Million218.41%
2011 -C$6.43 Million0.74%
2010 -C$6.38 Million-32.54%
2009 -C$9.45 Million-66.98%
2008 -C$28.62 Million-14.22%
2007 -C$33.36 Million7.04%
2006 -C$31.17 Million27.95%
2005 -C$24.36 Million4.51%
2004 -C$23.31 Million-15.84%
2003 -C$27.69 Million-55.29%
2002 -C$61.94 Million-34.05%
2001 -C$93.91 Million31.73%
2000 -C$71.29 Million31.56%
1999 -C$54.19 Million145.56%
1998 -C$22.07 Million76.4%
1997 -C$12.51 Million36.92%
1996 -C$9.14 Million